Abstract:Rationale: Tubulointerstitial fibrosis, which is closely related to functional injury of the kidney, can be observed in advanced stages of diabetic nephropathy (DN). Mammalian serine/threonine-protein kinase 4 (MST1), a core component of the Hippo pathway that is involved in cellular proliferation and differentiation, plays a crucial role in the pathogenesis of multiple metabolic diseases, kidney diseases and cancer. Methods: In type 1 and type 2 diabetic animals, as well as in human proximal tubular epithelial cells (HK-2), activation of MST1 was analyzed by immunohistochemistry and western blotting. In db/db mice, MST1 protein was knocked down or overexpressed by shRNA, and renal function, fibrosis, and downstream signaling were then investigated. RNA silencing and overexpression were performed by using an MST1 or YAP knockdown/expression lentivirus to investigate the regulation of MST1-mediated YAP/TEAD signaling pathways in the fibrosis process in HK-2 cells. Luciferase and coimmunoprecipitation (co-IP) assays were used to identify whether YAP directly regulated TEAD activation by forming a YAP-TEAD heterodimer, which ultimately leads to tubulointerstitial fibrosis. Results: MST1 activation was significantly decreased in type 1 and type 2 diabetic nephropathy. Notably, the downregulation of MST1 activation was also observed in HK-2 cells in a glucose- and time-dependent manner. In vivo, downregulation of MST1 was sufficient to promote renal dysfunction and fibrosis in db/m mice, whereas overexpression of MST1 ameliorated diabetic nephropathy-induced renal fibrosis. Further mechanistic study demonstrated that activated YAP induced by MST1 inhibition directly upregulated TEAD activation by binding to TEAD and forming a YAP-TEAD heterodimer, resulting in the promotion of epithelial-mesenchymal transition (EMT) and fibrosis in renal tubular epithelial. Conclusions: MST1 activation represents a potential therapeutic strategy to treat or prevent the progression of diabetic nephropathy-induced renal fibrosis.

MST1/2 in PDGFRα+ Cells Negatively Regulates TGF-β-induced Myofibroblast Accumulation in Renal Fibrosis

MST1/2 regulates fibro/adipogenic progenitor fate decisions in skeletal muscle regeneration

Mkp2 Inhibits Tgf-Beta 1-Induced Epithelial-To-Mesenchymal Transition In Renal Tubular Epithelial Cells Through A Jnk-Dependent Pathway

Mice Overexpressing Latent Tgf-Beta 1 Are Protected Against Renal Fibrosis In Obstructive Kidney Disease

Inactivation of MST1/2 Controls Macrophage Polarization to Affect Macrophage-Related Disease via YAP and Non-YAP Mechanisms

Mice overexpressing latent TGF-β1 are protected against renal fibrosis in obstructive kidney disease

Smad7 Inhibits Fibrotic Effect of TGF- on Renal Tubular Epithelial Cells by Blocking Smad2 Activation

Smad2 Protects Against TGF-β/Smad3-Mediated Renal Fibrosis

Activation of MST1 protects filtration barrier integrity of diabetic kidney disease in mice through restoring the tight junctions of glomerular endothelial cells

Proteasome Inhibitor MG132 Inhibits the Process of Renal Interstitial Fibrosis

Methyl-CpG-binding domain protein 2 contributes to renal fibrosis through promoting polarized M1 macrophages

Macrophages Regulate Renal Fibrosis Through Modulating TGFβ Superfamily Signaling

Tubule-Specific Mst1/2 Deficiency Induces CKD Via YAP and Non-YAP Mechanisms.

Downregulation of PDZK1 by TGF-β1 promotes renal fibrosis via inducing epithelial-mesenchymal transition of renal tubular cells

AKT Regulation of Mesothelial-to-mesenchymal Transition in Peritoneal Dialysis is Modulated by Smurf2 and Deubiquitinating Enzyme USP4

Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis

PDGFβ receptor-targeted delivery of truncated transforming growth factor β receptor type II for improving the in vitro and in vivo anti-renal fibrosis activity via strong inactivation of TGF-β1/Smad signaling pathway

MDM2 Mediates Fibroblast Activation and Renal Tubulointerstitial Fibrosis Via a P53-Independent Pathway.

Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFβ and Notch signaling and preserving PTEN expression.

Myeloid-specific Targeting of Notch Ameliorates Murine Renal Fibrosis Via Reduced Infiltration and Activation of Bone Marrow-Derived Macrophage

Rictor/mTORC2 signaling mediates TGFβ1-induced fibroblast activation and kidney fibrosis